AlphAIalphai — Financial news for AI agents
tradingview.comAUG 271 min read$DK

Delek US Director Sold Shares Worth Over $1.9M

Gary M. Sullivan Jr., a director of Delek US, sold 27,687 shares of the company's stock on August 24, 2026, at an average price of $69.01 per share, totaling $1.91 million. Post-sale, he owns 32,004 shares. The transaction was disclosed in an SEC Form 4 filing.

Original reporting
tradingview.com
Published Aug 27, 2026, 1:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 3:59 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Delek US Director Sold Shares Worth Over $1.9M — source image
Source · tradingview.com
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

Provides fresh data on insider holdings; useful for short‑term monitoring but not a catalyst for major price moves.

02

Market read

Insider sale adds to transparency; traders may watch for any follow‑up activity.

03

What to watch

Director retains a sizable stake, indicating continued confidence.

Relevance 5/10Novelty 5/10Timing: same-day filing

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$DKNeutralMedium confidence
Context

Director Gary M Sullivan Jr. sold $1.91M of Delek US common stock on 2026-08-24, reducing his holding to 32,004 shares.

Expected impact

Minor downward pressure, unlikely to move beyond a few cents.

Evidence & confidence

Sale size is notable but not large enough to signal major concerns; director remains a significant shareholder.

Market effects

Sector

No broader sector impact; insider sale is company‑specific.

Regional

Limited to U.S. energy sector investors.

Global

Minimal global relevance.

Counterpoint

What could challenge this read

Sale could be a routine diversification rather than a negative signal.

Key entities

  • Company
    Delek US Holdings, Inc.

    U.S. downstream energy company.

  • Insider
    Gary M Sullivan Jr.

    Director of Delek US who sold shares.

Read at source← All news

Related articles

AUG 24
$DKMed

Is DK a Buy Now as Cash Flow Improves Despite Refining Cycle Risks?

Delek US Holdings (DK) reported improved cash flow in Q2, with $262.9M from operations. Management expects $220M annual free-cash-flow improvement. DK trades at a forward P/E of 7.1 and P/S of 0.36. Risks include leverage, crack-spread volatility, and regulatory uncertainty. Zacks ranks DK as a Strong Buy with A-rated Value and Growth scores.

tradingview.com3 min
AUG 23
$DKMedAI 8/10

Up another 12% Friday, this AI-picked energy stock is now up +90%

Delek US Holdings (DK) surged 11.6% on Friday, reaching near a 52-week high of $71.47, extending its 90% gain since March. The energy company reported Q2 EPS of $5.48, beating estimates by 148%, with EBITDA up 279% quarter-over-quarter. InvestingPro's AI models identified Delek's potential before its rally, citing strong momentum, earnings turnaround, and cost discipline. The company's performance highlights include record refining margins and operational improvements. InvestingPro members recei

investing.com2 min
AUG 22
$DKHighAI 8/10

DK Surges As Delek US Earnings Smash Wall Street Targets

Delek US Holdings Inc. (DK) stock surged 11.54% after Q2 earnings beat expectations, with revenue of $4.09B and adjusted EPS up to $5.48. Analysts raised price targets, citing strong refining margins and cash flow. The company's leverage remains high, but cash generation supports dividends and debt reduction. DK's stock is technically in an uptrend, with support at $68 and resistance near $76.

stockstotrade.com2 min
AUG 9
$DKMed

Delek US Q2 Earnings Call Highlights

Delek US (NYSE: DK) Q2 earnings call covered refining margins, throughput guidance, and cash flow. Management said refined-product markets may take several quarters to normalize and that a less backwardated forward curve could lift realized crack spreads. Q3 throughput guided to 296,000-316,000 bpd, with Opex $220-$230M and D&A $110-$120M. Delek Logistics Partners reported ~$144M adjusted EBITDA and reaffirmed 2026 guidance of $520-$560M.

yahoo.com4 min
AUG 6
$DKMedAI 8/10

Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q2 2026 net income of $170 million ($2.71/share) and adjusted net income of $344 million ($5.48/share). Adjusted EBITDA was $639 million, with RVO-adjusted EBITDA of $490 million and RVO-adjusted EPS of $3.64. Logistics segment adjusted EBITDA was a record $144 million. DKL full-year 2026 EBITDA guidance is $520 million to $560 million.

fool.com6 min
AUG 5
$DKMed

Delek Slides on Q2 Results

Delek US Holdings (NYSE: DK) reported Q2 ended June 30, 2026 net income of $169.5M ($2.71/share) and adjusted net income of $343.9M ($5.48/share). Adjusted EBITDA was $638.7M; excluding RVO impacts, adjusted EPS was $3.64 and adjusted EBITDA $490.1M. Delek Logistics posted adjusted EBITDA of $143.5M and is targeting $520-560M. Delek bought $20M of DK shares and paid $15.6M in dividends, declaring a $0.255 quarterly dividend.

baystreet.ca3 min